Beigene, Ltd.
SEC CIK 1651308 · ONC · last insider filing 2026-06-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Oyler John | Director · Chief Executive Officer | filed 2016 - 2026 |
| Baker Julian | Director | filed 2016 - 2026 |
| Baker Felix | Director | filed 2016 - 2026 |
| Baker Bros. Advisors LP | Director | filed 2016 - 2026 |
| Hooper Anthony C | Director | filed 2020 - 2026 |
| Baker Brothers Life Sciences LP | Director | filed 2016 - 2026 |
| Sharp Shalini | Director | filed 2024 - 2026 |
| Brandicourt Olivier | Director | filed 2024 - 2026 |
| 667, L.P. | Director | filed 2016 - 2026 |
| Baker Bros. Advisors (GP) LLC | Director | filed 2016 - 2026 |
| Wang Xiaodong | Director | filed 2016 - 2026 |
| Riva Alessandro | Director | filed 2022 - 2026 |
| Dugan Margaret | Director | filed 2022 - 2026 |
| Sawyers Charles Lazelle | Director | filed 2026 - 2026 |
| Mooney Elizabeth Fisher | Director | filed 2026 - 2026 |
| Yi Qingqing | Director | filed 2016 - 2026 |
| Sanders Corazon (Corsee) D. | Director | filed 2020 - 2026 |
| Glazer Donald W. | Director | filed 2016 - 2024 |
| Malley Thomas | Director | filed 2016 - 2023 |
| su Jingshyh S | Director | filed 2018 - 2021 |
| Chen Timothy Yung-Cheng | Director | filed 2016 - 2021 |
| 14159, L.P. | Director | filed 2016 - 2017 |
| Tang Ke | Director | filed 2016 - 2017 |
| Krishana Ranjeev | Director | filed 2016 - 2016 |
| Goller Michael | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wu Xiaobin | President, COO & GM China | filed 2018 - 2026 |
| Wang Lai | President, Global Head of R&D | filed 2021 - 2026 |
| Lee Chan Henry | SVP, General Counsel | filed 2023 - 2026 |
| Ball Titus B. | Principal Accounting Officer | filed 2024 - 2026 |
| Rosenberg Aaron | Chief Financial Officer | filed 2024 - 2026 |
| Wang Julia Aijun | Chief Financial Officer | filed 2021 - 2024 |
| Huang Jane | CMO, Hematology | filed 2016 - 2021 |
| Liang Howard | CFO & Chief Strategy Officer | filed 2016 - 2021 |
| Peterson Amy C. | CMO, Immuno-oncology | filed 2016 - 2018 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | filed 2016 - 2018 |
| Yang Jianxin | Sr. VP, Head of Clinical Dev. | filed 2016 - 2016 |
| Yan Wendy Xiaojun | Sr. VP, Head of Reg. Affairs | filed 2016 - 2016 |
| Yuan Ruirong | Chief Medical Officer | filed 2016 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.